Tag: cholestatic pruritus market trends

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theCholestatic Pruritus Market?

The increasing prevalence of liver diseases is also expected to drive the growth of the cholestatic pruritus market. Cholestatic pruritus is a symptom often associated with liver diseases, particularly those that disrupt bile flow, such as cirrhosis and hepatitis. The growing incidence of liver diseases due to factors like obesity, diabetes, alcohol consumption, and viral infections has made cholestatic pruritus a significant concern in diagnosing and managing liver conditions. In July 2023, the Office for Health Improvement and Disparities reported that hospital admissions for liver disease in England had increased by 22% between 2022 and 2023. As liver diseases continue to rise, the demand for effective treatments for cholestatic pruritus will increase, driving the growth of the market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp

#What Are the Key Projections for the CAGR of the Cholestatic Pruritus Market From 2025 to 2034?

The cholestatic pruritus market has seen strong and consistent growth, expected to rise from $19.20 billion in 2024 to $20.28 billion in 2025 at a CAGR of 5.6%. Contributing factors include a rising prevalence of skin disorders, increased investments in R&D, a growing demand for effective treatments, heightened awareness, and a favorable regulatory environment.

The cholestatic pruritus market is expected to witness strong growth, reaching $24.97 billion by 2029 at a CAGR of 5.3%. Factors contributing to this growth include a growing elderly population, an increasing prevalence of atopic dermatitis and urticaria, a rising incidence of chronic kidney diseases, and a higher occurrence of conditions linked to pruritus. Notable trends include the introduction of new treatment options, strategic partnerships for cholestatic pruritus research, advancements in treatment modalities, the expansion of healthcare facilities, and continued technological innovation.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21140

What Key Market Trends and Innovations Are Shaping the Future of theCholestatic Pruritus Industry?

Leading companies in the cholestatic pruritus market are concentrating on creating innovative solutions, such as oral medications, to enhance symptom management, improve patient adherence, and offer targeted relief by addressing the root causes of bile salt buildup and inflammation. An oral medication for cholestatic pruritus is a liquid treatment formulated to reduce bile acid buildup and ease severe itching in cholestasis patients. For example, in March 2024, Mirum Pharmaceuticals Inc., a biopharmaceutical company based in the US, received FDA approval for LIVMARLI (maralixibat) oral solution to treat cholestatic pruritus in patients aged five and older with progressive familial intrahepatic cholestasis (PFIC). This once-daily, orally administered ileal bile acid transporter inhibitor has a breakthrough therapy designation for PFIC type 2 and is expected to significantly benefit patients with cholestatic pruritus associated with PFIC, offering a much-needed treatment for rare subtypes.

Which Companies Are Leading the Charge in Expanding theCholestatic Pruritus Market Growth?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

How is the Global Cholestatic Pruritus Market Segemented?

The cholestatic pruritus market covered in this report is segmented –

1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types

2) By Treatment Type: Medications, Phototherapy, Other Treatment Types

3) By Route Of Administration: Oral, Topical, Injectable

4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21140&type=smp

Which Geographics are Influencing the Growth of the Cholestatic Pruritus Market?

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Cholestatic Pruritus Market 2025, By The Business Research Company:

Histoplasmosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/histoplasmosis-treatment-global-market-report

Intestinal Pseudo-Obstruction Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Small Cell Lung Cancer Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the cholestatic pruritus market grown in recent years?

The market size for cholestatic pruritus has experienced robust growth in the past few years. The projection suggests an increase from $19.20 billion in 2024 to $20.28 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.6%. Factors contributing to this growth during the historical phase include an increase in skin disorder cases, expanded investments in research and development, the need for effective treatments, heightened disease awareness, and supportive regulations.

How is the cholestatic pruritus market size expected to evolve during the forecast period?

Strong expansion is anticipated in the cholestatic pruritus market in the coming years, with an expected valuation of $24.97 billion by 2029, reflecting a 5.3% compound annual growth rate (CAGR). The projected increase in the market during this forecast period can be linked to various factors such as a growing elderly demographic, a rise in atopic dermatitis and urticaria cases, an uptick in the geriatric demographic, heightened incidences of chronic kidney diseases, and a growing prevalence of conditions leading to pruritus. The forthcoming period will witness prominent trends such as the advent of novel treatment alternatives, collaborations with leading corporations for cholestasis pruritus research, advances in treatment methodologies, extensive development of healthcare infrastructures, and technological breakthroughs.

Get your cholestatic pruritus market report here!

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Which key drivers are propelling the cholestatic pruritus market’s growth?

The escalation in the occurrence of liver diseases is projected to stimulate the expansion of the cholestatic pruritus market in the future. The liver disease umbrellas various conditions that hinder liver functionality, encompassing infections, auto-immune disorders, genetic diseases, and damage from toxins that result in inflammation, scarring, or liver failure. The escalating incidence of liver diseases has been stoked by the rise in obesity, diabetes, alcohol consumption, viral hepatitis infections, and contact with toxins and environmental elements. Cholestatic pruritus facilitates the detection and control of liver diseases by acting as a pivotal symptom that specifies hampered bile flow, often instigating additional scrutiny and treatment of fundamental hepatic conditions. For example, in July 2023, as per the Office for Health Improvement and Disparities, a UK government body tasked with resolving health inequalities, hospital intakes for liver disease in England saw a 22% increase in 2022, escalating from 67,458 to 82,290. Hence, the escalating incidence of liver diseases will catalyze the expansion of the cholestatic pruritus market.

What are the market segments in the cholestatic pruritus industry?

The cholestatic pruritus market covered in this report is segmented –

1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types

2) By Treatment Type: Medications, Phototherapy, Other Treatment Types

3) By Route Of Administration: Oral, Topical, Injectable

4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp

Which leading companies are shaping the growth of the cholestatic pruritus market?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.

What are the key trends shaping the future of the cholestatic pruritus market?

Key players in the cholestatic pruritus industry are channeling their efforts into the creation of novel solutions such as oral formulations aimed at managing symptoms more effectively. They seek to enhance patient adherence to medication and supply targeted relief at the root of bile salt build-up and inflammation. Essentially, an oral formulation for treating cholestatic pruritus is a liquid drug mix prepared to lower bile acid build-up and mitigate intense itching in cholestasis patients. For instance, in March 2024, the U.S. Food and Drug Administration (FDA) gave approval to Mirum Pharmaceuticals Inc, a biopharmaceutical company based in the US, for their LIVMARLI (maralixibat) oral solution. This medication, designed for the treatment of cholestatic pruritus in patients five years and older suffering from progressive familial intrahepatic cholestasis (PFIC), is administered once daily. A breakthrough therapy designation for PFIC type 2 has been granted to this orally administered ileal bile acid transporter inhibitor. LIVMARLI is set to tremendously impact patients with cholestatic pruritus associated with PFIC by providing a crucial treatment alternative for those with the rarest subtypes.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21140

Which geographic areas are influencing the growth of the cholestatic pruritus market?

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Histoplasmosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/histoplasmosis-treatment-global-market-report

Intestinal Pseudo-Obstruction Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Small Cell Lung Cancer Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Anticipated CAGR of the Cholestatic Pruritus Market, and What Factors Will Drive It?

The market size for cholestatic pruritus has witnessed robust expansion in the last few years. It is projected to amplify from $19.20 billion in 2024 to $20.28 billion in 2025, maintaining a compound annual growth rate (CAGR) of 5.6%. The growth throughout the historical period can be credited to the surge in incidents of skin conditions, an escalation in research and development investments, the call for effective treatments, heightened recognition of the sickness, and supportive regulatory conditions.

Anticipations point towards a robust expansion in the cholestatic pruritus market size in the coming years, with predictions reaching $24.97 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.3%. This projected development during the forecast period is primarily credited to the surge in the aged population, the escalating incidences of atopic dermatitis and urticaria, an increase in elderly population, the rise in chronic kidney maladies, and the expanding prevalence of conditions related to pruritus. Prominent trends projected during the forecast period encompass the emergence of new treatment alternatives, collaborations with leading enterprises for cholestasis pruritus investigation, revolutions in treatment methodologies, enhancement of healthcare facilities, and technological advancements.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Cholestatic Pruritus Market?

The escalating rates of liver disease are anticipated to stimulate the expansion of the cholestatic pruritus market in the future. There’s a wide spectrum of disorders – including infections, autoimmune diseases, genetic conditions, and toxin-induced damage – that jeopardizes the function of the liver, often birthing inflammation, scarring, or liver failure. The increasing occurrence of these liver conditions is spurred on by mounting obesity rates, diabetes, alcohol consumption, viral hepatitis infections, and prolonged exposure to harmful toxins and environmental influences. Cholestatic pruritus plays a vital role in detecting and managing liver diseases by emerging as a primary symptom signaling hindered bile flow, thus necessitating further examination and addressing of root hepatic problems. To illustrate, in July 2023, the Office for Health Improvement and Disparities, an entity of the UK government committed to mitigating health disparities, stated that hospital admissions for liver disease in England saw a 22% surge for the year ending in 2022, jumping from 67,458 to 82,290. Consequently, the rising incidence of liver diseases will be a catalyst for the expansion of the cholestatic pruritus market.

Explore Comprehensive Insights Into The Global Cholestatic Pruritus Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21140&type=smp

Who Are the Top Companies Contributing to the Growth of the Cholestatic Pruritus Market?

Major companies operating in the cholestatic pruritus market are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Merck KGaA, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Incyte Corporation, Ipsen Pharma, Vanda Pharmaceuticals Inc., Medison Pharma Ltd., Mirum Pharmaceuticals Inc., Albireo Pharma Inc., Dipharma Francis S.r.l., Cara Therapeutics Inc., CANbridge Pharmaceuticals Inc., Escient Pharmaceuticals Inc., Tharimmune Inc., Vifor Fresenius Medical Care Renal Pharma, CymaBay Therapeutics Inc., ICE Pharma Inc., Aquatic Remedies Private Limited.

How Are Technological Trends Affecting the Growth and Development of the Cholestatic Pruritus Market?

Key players within the cholestatic pruritus market are investing in the creation of novel solutions to tackle symptoms, enhancing patient comfort, and provide targeted relief by addressing root causes such as bile salt accumulation and inflammation. Liquid formulations, or oral solutions, for cholestatic pruritus are being developed aimed at reducing bile acid buildup and soothing intense itching associated with cholestasis. For example, in March 2024, U.S. biopharmaceutical firm, Mirum Pharmaceuticals Inc., acquired approval from the U.S. Food and Drug Administration for LIVMARLI (maralixibat), an oral solution designed to treat cholestatic pruritus in patients aged five and up diagnosed with progressive familial intrahepatic cholestasis (PFIC). This daily, orally taken inhibitor of ileal bile acid transporter has secured breakthrough therapy status for PFIC type 2. LIVMARLI is set to greatly benefit patients dealing with cholestatic pruritus associated with PFIC, providing a much required therapy alternative for individuals with the rare subtypes.

Secure Your Global Cholestatic Pruritus Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/cholestatic-pruritus-global-market-report

Which Segments of the Cholestatic Pruritus Market Hold the Most Potential for Future Development?

The cholestatic pruritus market covered in this report is segmented –

1) By Disease Type: Primary Biliary Cholangitis (PBC), Primary Sclerosing Cholangitis (PSC), Intrahepatic Cholestasis of Pregnancy (ICP), Other Disease Types

2) By Treatment Type: Medications, Phototherapy, Other Treatment Types

3) By Route Of Administration: Oral, Topical, Injectable

4) By End-User: Hospitals, Clinics, Ambulatory Care Centers, Homecare

Subsegments:

1) By Primary Biliary Cholangitis (PBC): Early-Stage PBC, Advanced PBC, PBC With Cirrhosis, PBC With Liver Failure

2) By Primary Sclerosing Cholangitis (PSC): Classic PSC, PSC With Ulcerative Colitis, PSC With Bile Duct Strictures

3) By Intrahepatic Cholestasis of Pregnancy (ICP): Mild ICP, Severe ICP, ICP With Preterm Birth Risk

4) By Other Disease Types: Alcoholic Cholestasis, Drug-Induced Cholestasis, Viral Hepatitis-Induced Cholestasis, Genetic Cholestasis Disorders

What Are the Key Regions Powering Growth in the Cholestatic Pruritus Market?

North America was the largest region in the cholestatic pruritus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cholestatic pruritus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Defines the Scope of the Cholestatic Pruritus Market?

Cholestatic pruritus refers to severe itching caused by the buildup of bile acids in the skin, typically resulting from liver diseases that impair bile flow. This condition can significantly affect a patient’s quality of life and often requires targeted treatment to manage the discomfort and address the underlying liver dysfunction.

Browse Through More Similar Reports By The Business Research Company:

Histoplasmosis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/histoplasmosis-treatment-global-market-report

Intestinal Pseudo-Obstruction Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Small Cell Lung Cancer Therapeutics Global Market Report 2025

https://thebusinessresearchcompany.com/report/small-cell-lung-cancer-therapeutics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: